Assessing Pathological Complete Response in Locally Advanced Breast Cancer: The Role of Inflammatory and Nutritional Biomarkers


Creative Commons License

Duran E. N., Yeniyurt E. K., Aydın S. G., ERKİNÜRESİN T., Dağıstanlı S., İşbilen Z. B. Y., ...Daha Fazla

Acta Haematologica Oncologica Turcica, cilt.58, sa.2, ss.103-109, 2025 (Scopus, TRDizin)

Özet

Aim: Neoadjuvant chemotherapy (NAC) aims to achieve pathological complete response (pCR), which is linked to improved outcomes in locally advanced breast cancer (LABC). Identifying reliable predictors of pCR remains a clinical priority. Methods: This retrospective study included 44 women, with a median age of 50 years, with stage 2B-3C breast cancer who underwent NAC followed by surgery. Inflammatory markers [systemic inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), erythrocyte-to-lymphocyte ratio (ELR), lymphocyte-to-C (LCR)] and nutritional indices [glucose-to-albumin ratio (GAR), hemoglobin-to-albumin ratio (HAR), prognostic nutritional index (PNI)] were analyzed. Receiver operating characteristic analysis determined optimal cut-off values, and binary logistic regression evaluated independent predictors of pCR. Results: The overall pCR rate was 38.6%. Among histological subtypes, luminal B tumors were more frequent in both groups, with 40.7% in the non-pCR group and 29.4% in the pCR group. Triple-positive and HER2-positive tumors were more common in the pCR group. GAR ≤2.04 emerged as the only independent predictor of pCR (odds ratio=0.09, 95% confidence interval: 0.01-0.70, p=0.02). ELR >2.69 and LCR >0.64 showed significant associations with pCR (p=0.03 and p=0.04, respectively), though they lacked independent predictive value. SII, NLR, PLR, HAR, and PNI demonstrated no significant correlation with pCR. Conclusion: This study assessed significant cut-off values, ELR >2.69 and LCR >0.64, that might predict the pCR in LABC. GAR, with a cut-off value of 2.04, was found to be an independent predictive marker for pCR.